Skip to main content
Log in

Vergleichende in vitro Untersuchungen zur Hämoperfusion mit verschiedenen Adsorbentien

In vitro evaluation of adsorbents used in haemoperfusion

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The properties of six adsorbents for Haemoperfusion were investigated in vitro: Amberlite XAD-2; Amberlite XAD-4; Haemocol; collodion coated charcoal; albumine-collodion encapsulated charcoal and activated carbon fibers. Carbromal and diazepam are most quickly removed from aqueous solutions by Amberlite XAD-2 and XAD-4. Of the charcoal containing materials, Haemocol eliminates most rapidly carbromal and diazepam; while activated carbon fibers remove phenobarbital faster. When heparinized blood is perfused, a remarkable reduction in platelet count is observed. The drop is most pronounced with Amberlite XAD-2 and XAD-4, but even when using charcoal preparations the platelet depletion can reach 10% of the original number over 5 hours. Haemolysis is most pronounced with Amberlite XAD-2, XAD-4 and Haemocol. As the efficiency of the adsorbents towards the various drugs differ and as their adverse effects also vary, the decision for a particular material will have to be made according to the individual case.

Zusammenfassung

In der vorliegenden Arbeit werden die Adsorptionseigenschaften von 6 verschiedenen Materialien, die bei der Hämoperfusion eingesetzt werden in vitro geprüft: Amberlite XAD-2 und XAD-4, Haemocol, Collodium verkapselte Aktivkohle, Collodium verkapselte und Albumin beschichtete Aktivkohle und Aktivkohle-Hohlfaser. Carbromal wird am schnellsten eliminiert von Amberlite XAD-2 und XAD-4, ebenso Diazepam. Beim Vergleich der verschiedenen Kohlepräparate werden Carbromal und Diazepam am schnellsten von Haemocol aus der Lösung entfernt, Phenobarbital von Aktivkohle-Hohlfaser, wenn man eine 5-stündige Perfusion zu Grunde legt. Die gerinnungsphysiologischen und klinisch-chemischen Untersuchungen mit Hilfe von heparinisiertem Frischblut lassen schwerwiegende Nebenwirkungen erkennen. Die Abnahme der Thrombozyten ist am ausgeprägtesten bei Amberlite XAD-2 und XAD-4, sie ist aber auch bei den Kohlepräparationen nachweisbar: Nach 5stündiger Hämoperfusion ist ihre Zahl auf bis zu 10% des Ausgangswertes abgefallen. Die Hämolyse ist besonders stark bei Amberlite XAD-2 und XAD-4, sowie Haemocol. Die je nach Giftstoff unterschiedlich große Adsorption der geprüften Materialien und ihre verschieden stark ausgeprägten Nebenwirkungen erfordern nach unseren Ergebnissen einen der individuellen Situation des Patienten angepaßten Einsatz.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Andrade, J. D., Kunitoma, K., van Wagenen, R., Kastigir, B., Gough, D., Kolff, W.J.: Coated adsorbents for direct blood perfusion: hema/activated carbon. Trans. Amer. Soc. Artif. Intern. Organs 17, 222 (1971)

    Google Scholar 

  2. Armstrong, C., Edwards, K.D.G.: Multifactorial design for testing oral ion exchange resins, charcoal and other factors in the treatment of aspirin poisoning in the rat. Efficacy of cholestyramine. Med. J. Aust.2, 301 (1967)

    Google Scholar 

  3. Babb, A.L., Popowich, R.P., Christopher, T.G., Scribner, B.H.: The genesis of the square meter-hour hypothesis. Trans. Amer. Soc. Artif. Intern. Organs17, 81 (1971)

    Google Scholar 

  4. Barakat, T., Mac Phee, I.W.: Experiments with an extracorporeal carbon column as a simplified artificial kidney. Br. J. Surg.57, 580 (1970)

    Google Scholar 

  5. Barakat, T., Mac Phee, I.W.: Bilirubin and alkaline phosphatase clearance from blood-plasma by perfusion through activated carbon. Br. J. Surg.58, 356 (1971)

    Google Scholar 

  6. Chang, T.M.S., Coffey, J.F., Lister, C., Taroy, E., Stark, A.: Methaqualone, methyprylone, and glutethimide clearance by the ACAC microcapsule artificial kidney: In vitro and in patients with acute intoxication. Trans. Amer. Soc. Artif. Intern. Organs19, 87 (1973)

    Google Scholar 

  7. Chang, T.M.S., Gonda, A., Dirks, J.H., Coffey, J.F., Leeburns, T.: ACAC microcapsule artificial kidney for the long term and short term management of eleven patients with chronic renal failure. Trans. Amer. Soc. Artif. Intern. Organs18, 465 (1972)

    Google Scholar 

  8. Chang, T.M.S., Gonda, A., Dirks, J.H., Malave, N.: Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using membrane coated activated charcoal. Trans. Amer. Soc. Artif. Intern. Organs17, 246 (1971)

    Google Scholar 

  9. Chang, T.M.S., Johnson, L.J., Ransome, O.J.: Semipermeable aqueous microcapsules. IV. Nonthrombogenic microcapsules with heparin-complexed membranes. Can. J. Physiol. Pharmacol.45, 705 (1967)

    Google Scholar 

  10. Chang, T.M.S., Malave, N.: The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney. Trans. Amer. Soc. Artif. Intern. Organs16, 141 (1970)

    Google Scholar 

  11. Chang, T.M.S., Pont, A., Johnson, L.J., Malave, N.: Response to intermittent extracorporeal perfusion through shunts containing semi-permeable microcapsules. Trans. Amer. Soc. Artif. Intern. Organs14, 163 (1968)

    Google Scholar 

  12. Davis, T.A., Cowsar, D.R., Harrison S.D. Jr., Tanquary, A.C.: Activated carbon fibers for hemoperfusion. Trans. Amer. Soc. Artif. Intern. Organs20, 353 (1974)

    Google Scholar 

  13. Decker, W.J., Combs, H.F., Treuting, J.J., Banez, R.J.: Dialysis of drugs against activated charcoal. Toxicol. Appl. Pharmacol.18, 573 (1971)

    Google Scholar 

  14. DeMyttenaere, M.H., Maher, J.F., Schreiner, G.E.: Hemoperfusion through a charcoal column for glutethimide poisoning. Trans. Amer. Soc. Artif. Intern. Organs13, 190 (1967)

    Google Scholar 

  15. Denti, E., Luboz, M.P., Tessore, V.: Adsorption characteristics of cellulose acetate coated charcoals. J. Biomed. Mater. Res.9, 143 (1975)

    Google Scholar 

  16. Dost, F.H.: Grundlagen der Pharmakokinetik, 2. Aufl., S. 311, Stuttgart: Verlag Georg Thieme, 1968

    Google Scholar 

  17. Dunea, G., Kolff, W.J.: Clinical experience with the Yatzidis charcoal artificial kidney. Trans. Amer. Soc. Artif. Intern. Organs11, 178 (1965)

    Google Scholar 

  18. Dunlop, E.H., Gazzard, B.G., Langley, P.G., Weston, M.J., Cox, L.R., Williams, R.: Design features of haemoperfusion columns containing activated charcoal. Med. Biol. Eng.14, 220 (1976)

    Google Scholar 

  19. Dutton, R.C., Dedrick, R.L., Bull, B.S.: A simple technique for the experimental production of acute platelet deficiency. Thromb. Diath. Haemorrh.21, 367 (1969)

    Google Scholar 

  20. Gazzard, B.G., Portmann, B., Weston, M.J., Langley, P.G., Murray-Lyon, J.J.M., Dunlop, E.H., Flax, H., Mellon, P.J., Record, C.D., Ward, M.B., Williams, R.: Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet,1, 1301 (1974)

    Google Scholar 

  21. Grabensee, B., Königshausen, T., Schnurr, E.: Behandlung schwerer Schlafmittelvergiftungen durch extracorporale Hämoperfusion. Dtsch. Med. Wochenschr.101, 158 (1976)

    Google Scholar 

  22. Hagstam, K.E., Larsson, L.E., Thysell, H.: Experimental studies on charcoal haemoperfusion in phenobarbital intoxication and uraemia, including histopathologic findings. Acta Med. Scand.180, 593 (1966)

    Google Scholar 

  23. Hennemann, H., Naujoks, R., Gattenlöhner, W., Röckel, A., Kaßler, G., Reiners, W., Heidland, A.: Hämoperfusion bei Schlafmittelvergiftungen. Dtsch. Med. Wochenschr.101, 155 (1976)

    Google Scholar 

  24. Kennedy, A.C., Briggs, J.D., Young, N., Lindsay, R.M., Luke, R.G., Campbell, D.: Successful treatment of three cases of severe barbiturate poisoning. Lancet1, 995 (1969)

    Google Scholar 

  25. Kisser, W.: Über den Nachweis und die quantitative Bestimmung bromierter Harnstoffderivate in der Toxikologie. Arch. Toxicol.22, 404 (1967)

    Google Scholar 

  26. Leber, H.W.: Anwendung der Haemoperfusion am Menschen. Wissenschaftliche Informationen der Fresenius-Stiftung4, 30 (1975)

    Google Scholar 

  27. Leber, H.W., Geißler, R.H., Faber, M., Post, D.: Experimentelle Untersuchungen zur Frage der Effektivität von Dialyse und Hämoperfusion bei Bromcarbamidintoxikationen. Klin. Wschr.54, 517 (1976)

    Google Scholar 

  28. Lesch, P., Blume, U., Scheibe, G., Sussmann, P., Schmidt, F.W., Barthels, M., Okonek, S.: Hameoperfusion durch verkapselte Aktivkohle zur Therapie exogener und endogener Intoxikationen. Klin. Wschr.54, 509 (1976)

    Google Scholar 

  29. Lie, T.S., Kim, W.J., Rommelsheim, K., Holst, A.: Behandlung von Koma-Patienten durch extrakorporale Hämoperfusion mit Aktivkohle. Münch. Med. Wochenschr.118, 945 (1976)

    Google Scholar 

  30. Lindsay, R.M., Prentice, C.R.M., Davidson, J.F., Burton, J.A., McNicol, G.P.: Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br. Med. J.4, 454 (1972)

    Google Scholar 

  31. Linton, A.L., Luke, R.G., Briggs, J.D., Kennedy, A.C.: Haemodialysis in the treatment of severe barbiturate intoxication. Proc. Europ. Dial. Transpl. Ass.4, 293 (1967). Excerpta Medica Foundation. International Congress Series No. 155.

    Google Scholar 

  32. Martin, A.M., Mitchell, D.C., Gibbins, J.K., Devapal, D., Trinder, P.: Charcoal haemoperfusion in the management of severe poisoning. Br. Med. J.1, 392 (1975)

    Google Scholar 

  33. Medd, R.K., Widdop, B., Braithwaite, R.A., Rees, A.J., Goulding, R.: Comparison of haemoperfusion and heamodialysis in the therapy of barbiturate intoxication in dogs. Arch. Toxicol.31, 163 (1973)

    Google Scholar 

  34. Nealon, T.F., Sugerman, H., Shea, W., Fleegler, E.: An extracorporeal device to treat barbiturate poisoning. Use of anionexchange resins in dogs. J. Am. Med. Assoc.197, 118 (1966)

    Google Scholar 

  35. Oellerich, M., Külpmann, W.R., Haeckel, R., Heyer, R.: Determination of phenobarbital and phenytoin in serum by a mechanised enzyme immunoassay (EMIT) in comparison with a gas-liquid chromatographic method. J. Clin. Chem. Clin. Biochem.15, 353 (1977)

    Google Scholar 

  36. Okonek, S.: Hämoperfusion mit beschichteter Aktivkohle zur Behandlung akuter Intoxikationen durch Arzneimittel, Pflanzenschutzmittel oder Pilze. I. Arzneimittel. Med. Klinik71, 1120 (1976)

    Google Scholar 

  37. Röckel, A., Schmid, G., Rupp, P., Kult, J., Hennemann, H., Heidland, A.: Hämoperfusion mit Aktivkohle und Ionenaustauscher bei phalloidinvergifteten Ratten. Dtsch. Med. Wochenschr.101, 418 (1976)

    Google Scholar 

  38. Rosenbaum, J.L., Mandanas, R.: Treatment of phenobarbital intoxication in dogs with an anion-recirculation peritoneal dialysis technique. Trans. Amer. Soc. Artif. Intern. Organs13, 183 (1967)

    Google Scholar 

  39. Rosenbaum, J.L., Ronquillo, E., Argyres, S.N.: Column haemoperfusion and haemodialysis techniques to treat barbiturate intoxication in dogs. J. Albert Einstein Med. Cent.16, 163 (1968)

    Google Scholar 

  40. Rosenbaum, J.L., Winsten, S., Kramer, M.S., Moros, J., Raja, R.: Resin haemoperfusion in the treatment of drug intoxication. Trans. Amer. Soc. Artif. Intern. Organs16, 134 (1970)

    Google Scholar 

  41. Schreiner, G.E.: The role of haemodialysis (artificial kidney) in acute poisoning. Arch. Intern. Med.102, 896 (1958)

    Google Scholar 

  42. Schreiner, G.E., Teehan, B.P.: Dialysis of poisons and drugsannual review. Trans. Amer. Soc. Artif. Intern. Organs18, 563 (1972)

    Google Scholar 

  43. Vale, J.A., Rees, A.J., Widdop, B., Goulding, R.: Use of charcoal haemoperfusion in the management of severely poisoned patients. Br. Med. J.1, 5 (1975)

    Google Scholar 

  44. Voigtmann, R., v. Baeyer, H., Sieberth, H.G.: Hämoperfusion über Aktivkohle — eine wesentliche therapeutische Bereicherung bei schweren Intoxikationen. Med. Welt27, 752 (1976)

    Google Scholar 

  45. Widdop, B., Medd, R.K., Braithwaite, R.A., Rees, A.J., Goulding, R.: Experimental drug intoxication: Treatment with charcoal haemoperfusion. Arch. Toxicol.34, 27 (1975)

    Google Scholar 

  46. Wieth, J.O.: Hemodialysis in barbiturate poisoning. Int. Anesthesiol. Clin.4, 359 (1966)

    Google Scholar 

  47. Yatzidis, H.: A convenient haemoperfusion microapparatus over charcoal for the treatment of endogenous and exogenous intoxications. Its use as an effective artificial kidney. Proc. Europ. Dial. Transpl. Ass.1, 83 (1964)

    Google Scholar 

  48. Yatzidis, H.: The use of ion exchange resins and charcoal in acute barbiturate poisoning. In “Acute barbiturate poisoning” (Hrsg. H. Matthew) S. 228 (1971). Amsterdam: Excerpta Medica

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Külpmann, W.R., Oellerich, M., Blume, U. et al. Vergleichende in vitro Untersuchungen zur Hämoperfusion mit verschiedenen Adsorbentien. Klin Wochenschr 56, 1171–1178 (1978). https://doi.org/10.1007/BF01476861

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01476861

Key words

Schlüsselwörter

Navigation